This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated GABRA1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-GABRA1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~51.8 kDa | |
| Observed band | ≈52 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Cerebellum (IHC candidate; verify WB) +1 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Cleaved | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The PA1578 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | Rat Brain, Rat Brain (catalog PA1578) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | PA1578; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
GABRA1 is predicted at 51.8 kDa and observed at ≈52 kDa; the cause of their small difference is not established.
| Band at ≈52 kDa | Matches the empirical GABRA1 band; confirm identity with antibody and sample controls |
| Band above ≈52 kDa | N-linked glycosylation at Asn38 or Asn138 could affect migration, but a visible shift is unproven |
| Band below ≈52 kDa | Signal-peptide cleavage could lower mass relative to the precursor; confirm band identity |
| Weak band in whole-cell lysate | GABRA1 is a multi-pass membrane protein that may be underrepresented in the lysate |
| UniProt predicted mass | The 51.8 kDa precursor mass is close to the observed ≈52 kDa band |
| N-linked glycosylation at Asn38 | Could affect apparent mass, but no visible shift is established |
| N-linked glycosylation at Asn138 | Could affect apparent mass, but no visible shift is established |
| Signal peptide at residues 1–27 | Cleavage would reduce mature protein mass relative to the precursor; its band position is not supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| Weak or no signal | A membrane protein may be poorly recovered or transferred | Check membrane protein recovery, transfer, and a positive-control lysate |
| No band in lysate | GABRA1 may be underrepresented in the sampled lysate | Check a membrane-enriched fraction and a positive-control lysate |
| Band higher than expected | N-linked glycosylation could alter migration | Compare with a validated deglycosylation control and confirm band identity |
| Band lower than expected | Signal-peptide cleavage could lower mass relative to the precursor | Confirm band identity with a second antibody or an appropriate control |
| Multiple bands | Different glycosylation or processing states are possible but unconfirmed | Check band identity with a second antibody and compare appropriate processing controls |
| Broad smear instead of sharp band | Heterogeneous N-linked glycosylation is possible but unconfirmed | Compare with a validated deglycosylation control and check sample quality |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Cerebellum | synaptic glomeruli - capsule | High | Protein (IHC) | HPA → |
| Cerebral cortex | neuropil | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for GABRA1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
PA1578 is an anti-GABRA1 antibody listed for Western blot with human, mouse, and rat reactivity. Its supplied WB image shows two lanes of rat brain tissue lysate; the provided evidence does not show human or mouse WB samples.
Which to pick: PA1578 is the only listed option. Choose it if its stated reactivity fits your sample; the supplied WB image documents rat brain tissue lysate under the reported conditions.